title: [Alarming use of anti-VEGF therapy in premature infants].
authors.affiliation: Drottning Silvias barn- och ungdomssjukhus, Sahlgrenska universitetssjukhuset/Ostra, Göteborg. annalena.hard@oft.gu.se
authors.forename: Anna-Lena
authors.initials: AL
authors.lastname: Hård
authors.forename: Ann
authors.initials: A
authors.lastname: Hellström
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage* / Q000009:adverse effects; D000068258:Bevacizumab; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D058449:Intravitreal Injections; D012178:Retinopathy of Prematurity / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab